TrialJournal of comparative effectiveness research2026
Matching-adjusted indirect comparison of fruquintinib versus ramucirumab in advanced gastric or gastroesophageal junction adenocarcinoma.
Nan An et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.